Measurement methods and accuracy in copy number variation: failure to replicate associations of beta-defensin copy number with Crohn's disease.

The copy number variation in beta-defensin genes on human chromosome 8 has been proposed to underlie susceptibility to inflammatory disorders, but presents considerable challenges for accurate typing on the scale required for adequately powered case-control studies. In this work, we have used accurate methods of copy number typing based on the paralogue ratio test (PRT) to assess beta-defensin copy number in more than 1500 UK DNA samples including more than 1000 cases of Crohn's disease. A subset of 625 samples was typed using both PRT-based methods and standard real-time PCR methods, from which direct comparisons highlight potentially serious shortcomings of a real-time PCR assay for typing this variant. Comparing our PRT-based results with two previous studies based only on real-time PCR, we find no evidence to support the reported association of Crohn's disease with either low or high beta-defensin copy number; furthermore, it is noteworthy that there are disagreements between different studies on the observed frequency distribution of copy number states among European controls. We suggest safeguards to be adopted in assessing and reporting the accuracy of copy number measurement, with particular emphasis on integer clustering of results, to avoid reporting of spurious associations in future case-control studies.

[1]  H. Drummond,et al.  NOD2/CARD15, TLR4 and CD14 mutations in Scottish and Irish Crohn's disease patients: evidence for genetic heterogeneity within Europe? , 2004, Genes and Immunity.

[2]  Kristen K. Dang,et al.  CCL3L1 and HIV/AIDS susceptibility , 2009, Nature Medicine.

[3]  M. den Heijer,et al.  Accurate, high-throughput typing of copy number variation using paralogue ratios from dispersed repeats , 2006, Nucleic acids research.

[4]  Anthony J Brookes,et al.  Defensins and the dynamic genome: what we can learn from structural variation at human chromosome band 8p23.1. , 2008, Genome research.

[5]  L. Lehmann,et al.  Comparison of multiplex ligation-dependent probe amplification and real-time PCR accuracy for gene copy number quantification using the beta-defensin locus. , 2009, BioTechniques.

[6]  B. Rovin,et al.  The Influence of CCL 3 L 1 Gene – Containing Segmental Duplications on HIV-1 / AIDS Susceptibility , 2009 .

[7]  J. Satsangi,et al.  Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. , 2005, Canadian journal of gastroenterology = Journal canadien de gastroenterologie.

[8]  Joshua M. Korn,et al.  Integrated detection and population-genetic analysis of SNPs and copy number variation , 2008, Nature Genetics.

[9]  T. Ganz.  Defensins: antimicrobial peptides of innate immunity , 2003, Nature Reviews Immunology.

[10]  André Reis,et al.  Psoriasis is associated with increased beta-defensin genomic copy number. , 2008, Nature genetics.

[11]  K. Huse,et al.  High‐resolution mapping of the 8p23.1 beta‐defensin cluster reveals strictly concordant copy number variation of all genes , 2008, Human mutation.

[12]  M. Bamshad,et al.  Reply to: “CCL3L1 and HIV/AIDS susceptibility” and “Experimental aspects of copy number variant assays at CCL3L1” , 2009, Nature Medicine.

[13]  Bernhard Radlwimmer,et al.  A chromosome 8 gene-cluster polymorphism with low human beta-defensin 2 gene copy number predisposes to Crohn disease of the colon. , 2006, American journal of human genetics.

[14]  I. Nagaoka,et al.  Human beta-defensin-2 functions as a chemotactic agent for tumour necrosis factor-alpha-treated human neutrophils. , 2004, Immunology.

[15]  T. Ganz,et al.  Human defensin gene copy number polymorphisms: Comprehensive analysis of independent variation in α- and β-defensin regions at 8p22–p23 , 2005 .

[16]  I. Nagaoka,et al.  Human β‐defensin‐2 functions as a chemotactic agent for tumour necrosis factor‐α‐treated human neutrophils , 2004 .

[17]  J. Satsangi,et al.  Dysregulation of Human β-Defensin-2 Protein in Inflammatory Bowel Disease , 2009, PloS one.

[18]  Jake K. Byrnes,et al.  Genome-wide association study of copy number variation in 16,000 cases of eight common diseases and 3,000 shared controls , 2010, Nature.

[19]  Suhaili Abu Bakar,et al.  Allelic recombination between distinct genomic locations generates copy number diversity in human β-defensins , 2009, Proceedings of the National Academy of Sciences.

[20]  Tomas W. Fitzgerald,et al.  A robust statistical method for case-control association testing with copy number variation , 2008, Nature Genetics.

[21]  A. Hoeft,et al.  Screening of copy number polymorphisms in human beta-defensin genes using modified real-time quantitative PCR. , 2006, Journal of immunological methods.

[22]  J. Phair,et al.  CCL3L1 and HIV/AIDS susceptibility , 2009, Nature Medicine.

[23]  J. Satsangi,et al.  Edinburgh Research Explorer Dysregulation of Human beta-Defensin-2 Protein in Inflammatory Bowel Disease , 2009 .

[24]  K. Mossman.  The Wellcome Trust Case Control Consortium, U.K. , 2008 .

[25]  M. Bamshad,et al.  Reply to: "Experimental aspects of copy number variant assays at CCL3L1". , 2009, Nature medicine.

[26]  D. Clayton,et al.  Experimental aspects of copy number variant assays at CCL3L1 , 2009, Nature Medicine.

[27]  J. Lennard-jones,et al.  Classification of inflammatory bowel disease. , 1989, Scandinavian journal of gastroenterology. Supplement.

[28]  S. Steer,et al.  Evidence for an influence of chemokine ligand 3-like 1 (CCL3L1) gene copy number on susceptibility to rheumatoid arthritis , 2007, Annals of the rheumatic diseases.

[29]  S. Fisher,et al.  A nonsynonymous SNP in ATG16L1 predisposes to ileal Crohn's disease and is independent of CARD15 and IBD5. , 2007, Gastroenterology.

[30]  R. W. Bentley,et al.  Association of Higher DEFB4 Genomic Copy Number With Crohn's Disease , 2010, The American Journal of Gastroenterology.

[31]  Simon C. Potter,et al.  Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls , 2007, Nature.

[32]  Jake K. Byrnes,et al.  Genome-wide association study of copy number variation in 16,000 cases of eight common diseases and 3,000 shared controls , 2010 .

[33]  J. Barber,et al.  Extensive normal copy number variation of a beta-defensin antimicrobial-gene cluster. , 2003, American journal of human genetics.

[34]  D. Clayton,et al.  Population structure, differential bias and genomic control in a large-scale, case-control association study , 2005, Nature Genetics.

[35]  S. Mccarroll.  Copy-number analysis goes more than skin deep , 2008, Nature Genetics.

[36]  J. Davies,et al.  Beta-defensin genomic copy number is not a modifier locus for cystic fibrosis , 2005, Journal of Negative Results in BioMedicine.